Emicizumab Prophylaxis in People with Moderate or Mild Hemophilia A Aged ≥40 Years, with and without Comorbidities - Findings from the Phase III HAVEN 6 Study
Jiménez-Yuste, Víctor ; Tzeng, Eunice ; Lim, Elise ; Ventriglia, Giuliana ; Shapiro, Amy D. ; Oldenburg, Johannes ; Mahlangu, Johnny
Blood, 2023-11, Vol.142 (Supplement 1), p.5495-5495 [Periódico revisado por pares]Texto completo disponível